Exome Asset Management »

Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Exome Asset Management

Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Karyopharm Therapeutics Inc note 3.000%10/1

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 2.0M 0.76

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bridgebio Pharma (BBIO)
Structure Therapeutics Sponsored Ads (GPCR)
Tg Therapeutics (TGTX)
Align Technology (ALGN)
Cigna Corp (CI)
Gilead Sciences (GILD)
Geron Corporation (GERN)
Biontech Se Sponsored Ads (BNTX)
Bristol Myers Squibb (BMY)
Miragen Therapeutics (VRDN)
Intuitive Surgical Com New (ISRG)
Beigene Sponsored Adr (BGNE)
Blueprint Medicines (BPMC)

View all positions for Exome Asset Management

Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1

Affinity Asset Advisors
Opaleye Management
Capstone Investment Advisors
Exome Asset Management
BLB^B Advisors
Jpmorgan Chase & Co

View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1